Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Spekulatius who wrote (62015)	5/17/2019 9:55:57 AM
From: Wallace Rivers	Respond to of 78658

I purchased CVS a few weeks back, underwater on that position. I am looking at AVX (which I have owned previously, years ago), some on this thread have purchased a similar company, KEM. What initially attracted me to AVX was its stellar balance sheet, the company carries zero debt. Certainly not the "sexiest" stock, and trades thinly. Anyone with an opinion on AVX?

To: Spekulatius who wrote (62015)	5/19/2019 1:06:49 PM
From: bruwin	Respond to of 78658

Seems I overlooked the fact that I was scrutinizing a Quarterly and not an Annual. The 3.8% yield is a fair one .... The Money Market Rate in the US seems to be between 2% to 2.4%. But debt is debt. And FCF can be derived from "Cash from Operations - Capital Expenditures", derived from within the Cash Flow Statement. And its 3 prime numbers contribute to "Cash & Equivalents" on the "Asset" side of the Balance Sheet. And the Balance Sheet is Share Capital + Retained Income = Total Assets - Total Liabilities. And Retained Income is Topped Up by the Net Income (Bottom Line) of the Income Statement, after any Dividends paid. So if no new shares are issued, it seems that one could consider that it's the outcome of the Income Statement that will largely determine when and how CVS's debt will get paid. There's an indicator that I observe, that was derived from someone in my part of the world, that is tending to show that CVS is heading towards a Buy scenario in the medium term. Should be interesting to see how it turns out .....